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Abstract. Inositol 1,4,5-trisphosphate receptors (IP3Rs) are intracellular mem-
brane calcium channels essential for the release of calcium from intracellular stores.
They form pathways for Ca2+ release that amplies signals transmitted via plasma
membrane receptors and so mediate a large array of calcium-regulated signal trans-
duction events, from control of gene expression, through regulation of cell prolif-
eration and other functions, to cell death. Molecular properties, expression and
regulation of IP3Rs have been recently reviewed by others and thus these aspects
will be mentioned only brieﬂy in this article. This minireview will focus on the
transcriptional regulation of IP3Rs and their modulation by phosphorylation.
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The inositol 1,4,5-trisphosphate receptors (IP3Rs) are intracellular membrane cal-
cium channels essential for calcium release from intracellular stores. They mediate
the calcium-mobilising eect of a wide range of hormones, cytokines and neuro-
transmitters. Activation of these receptors results in intracellular calcium signals
that display impressive delity, frequently manifested through a complex array of
temporal and spatial characteristics (Yule 2001). Molecular cloning has identied
three isoforms of IP3Rs, IP3Rt y p e1 ,2a n d3( I P 3R-1, -2 and -3). All three iso-
forms are 60{70% homologous and vary in their tissue distribution and hugely in
their levels of expression (Berridge 1993; Taylor et al. 1999). The IP3R consists of
homotetramers or heterotetramers of IP3R isoform subunits with approximately
2,700 amino acids per subunit, having approximate molecular mass of 300 kDa.
Each subunit contains three functionally distinct regions: the transmembrane ion
channel pore domain at the C-terminal end, the IP3-binding domain at the N-
terminal region and the modulatory (transduction) domain between them (Patel
et al. 1999; Thrower et al. 2001; Bosanac et al. 2002). The transmembrane domain
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Figure 1. Structure of the IP3 receptor. IP3R contains three functionally distinct regions:
I, transmembrane ion channel pore domain at the C-terminal end; II, IP3-binding domain
at the N-terminal region; and III, modulatory domain between them. Modulatory domain
contains binding sites for calcium, ATP and calmodulin, but also alternatively spliced S2
region.
contains 6 transmembrane segments, with a pore forming region between segments
5 and 6 (Figure 1). Majority of the calcium binding sites occurs in the modula-
tory domain, where also the putative binding sites for calmodulin and adenosine
triphosphate (ATP) are localised.
The three-dimensional structure of the IP3R-1 was reported at a 2.4 nm reso-
lution (Jiang et al. 2002). The structure of IP3R-1 was strikingly dierent from that
of the ryanodine receptor calcium release channel. The IP3R assumes the shape of
an uneven dumbbell with one end signicantly larger than the other. The larger
bulky end with four arms protruding laterally by about 5 nm was suggested to con-
stitute the cytoplasmic side of the protein. The IP3R is about 17 nm high and the
lateral dimension is about 15.5 nm. The smaller end, the lateral dimension of which
is about 10 nm, probably forms the membrane-spanning domain with the central
pore. Recently, the crystal structure of the IP3-binding core of IP3R-1 in complex
with IP3 (residues 226{576) at a 0.22 nm resolution has been presented (Bosanac
et al. 2002). The cleft formed between an N-terminal -trefoil domain (residues
224{436) and a C-terminal -helical domain containing an `armadillo repeat'-like
fold (residues 437{604) exposes a cluster of arginine and lysine residues that coor-IP3 Receptors, Transcriptional Regulation, Phosphorylation 297
dinate the three-phosphoryl groups of IP3. Residues E425, D426, E428, D442 and
D444 have been shown to be essential for the coordination of Ca2+ ( S i e n a e r te ta l .
2002). These residues within the IP3-binding domain are a part of the two putative
Ca2+-binding sites. This leads to a tempting speculation on the Ca2+-IP3 coupling
mechanism required for channel activation. Binding of Ca2+ to the IP3R-1 induced
marked structural changes in the tetrameric receptor, indicating that Ca2+ ions
regulate IP3R gating activity through the rearrangement of functional domains
(Hamada et al. 2002).
IP3R interacts physically with many proteins (for a review see Bultynck et al.
1999). All IP3R subtypes interact with talin, a focal contact cytoskeletal protein,
vinculin and -actin (Sugiyama et al. 2000). A direct interaction between IP3Rs and
myosin II regulates local organisation of IP3 signalling in C. elegans (Walker et al.
2002). Interaction with the store-operated channel/Ca2+-release calcium channel
(CRAC), with HIV-1 pathogenicity factor, or with homer proteins in the longitu-
dinal sarcoplasmic reticulum of skeletal muscle bres were observed (Lewis 2001;
Manninen and Saksela 2002; Salanova et al. 2002). Yoo et al. (2000, 2001) showed
complex formation between IP3Rs and chromogranins A and B in the native state
in the secretory granules of bovine adrenal medullary chroman cells.
The IP3R-1 is predominantly expressed in the central nervous system, particu-
larly in the cerebellum. The IP3R-2 is present in many tissues; high levels are found
in the spinal cord and glial cells. The IP3R-3 is found in the kidney, brain, gas-
trointestinal tract and pancreatic islets (Furuichi et al 1990; Miyakama et al. 1999).
IP3Rs are most abundantly expressed in intracellular membranes of the organelles,
e.g. in the endoplasmic reticulum, the nuclear envelope, the Golgi apparatus, and
possibly in secretory vesicles (for review see Taylor et al. 1999; Nakanishi et al.
1996). IP3Rs are also expressed in the plasma membrane of some cells (Putney
1997; Lischka et al. 1999; Tanimura et al. 2000). Recently it was found that IP3Rs
are functionally involved in the store-operated calcium inﬂux, mitochondrial cal-
cium homeostasis, and excitation-contraction coupling in the atrium (Kiselyov et
al. 1998; Hajnoczky et al. 2000; Lipp et al. 2000; Gilabert et al. 2001).
Chronic stimulation of receptors linked to the formation of IP3 led, over a
period of several hours, to a massive decrease in the number of IP3Rs, a decrease
in sensitivity of the intracellular Ca2+ stores to IP3, and also a decrease in the fre-
quency of Ca2+ pus (Wojcikiewicz and Nahorski 1991; Wojcikiewicz et al. 1992;
Tovey et al. 2001). Such adaptive decreases in IP3 sensitivity have now been ob-
served in many cell types. The large conformational changes that follow IP3 binding
to its receptors seem to be the essential trigger for IP3R degradation (Zhu et al.
1999). Poly-ubiquitination, covalent attachment of the short protein, ubiquitin, to
lysine residues of a target protein of IP3R, followed by degradation in proteasomes
(the ubiquitin/proteasome pathway) was suggested in the process of degradation
(Hershko and Ciechanover 1998; Oberdorf et al. 1999). Phosphorylation of Ser-1588
and 1755 did not inhibit IP3R poly-ubiquitination (Wojcikiewicz et al. 2003).
IP3R subtypes dier markedly in their response to endogenous as well as ex-
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Ca2+, ATP, phosphorylation, on IP3Rs were recently reviewed (Taylor 1998; Patel
et al. 1999; Iino 2000; Thrower et al. 2001) and we will focus only on some of them.
It is generally accepted that IP3R is activated only in the presence of IP3.
However, the recently discovered family of calmodulin (CaM)-like neuronal Ca2+
sensor proteins called Ca2+-binding proteins (CaBPs/caldendrin) were reported to
activate IP3R in the absence of IP3 (Yang et al. 2002). Moreover, chromogranin
A, which forms a complex with IP3R, drastically increased IP3R channel activity
in the secretory granules of bovine adrenal medullary chroman cells (Thrower et
al. 2002).
Single channel properties of IP3Rs were obtained mostly in bilayer lipid mem-
branes, where Ca2+ was used as an ion carrier. Cytosolic Ca2+, binding directly
to IP3R, exerts a bell-shaped dependence on the IP3R-1. Low concentrations of
calcium (200{300 nmol/l) increase channel activity in the presence of IP3, while
high Ca2+ concentrations inhibit it (Iino 1990; Bezprozvanny et al. 1991). It was
reported that the Ca2+ dependence of single IP3R-2 is not bell-shaped and that
IP3R-3 is not inhibited at high Ca2+ concentrations (Hagar et al. 1998). However,
the inhibitory eect of calcium on all types of IP3R is still controversial, since it
was not observed in other studies (Swatton et al. 1999; Missiaen et al. 1998 ; Mak
et al. 2000).
In presence of the IP3, ATP increases activity of IP3Rs (Bezprozvanny and
Ehrlich 1993) by binding to two high anity sites on the IP3R-1 or to one binding
site on the IP3R-3 (Maes et al. 2000). At higher concentrations (0.5 mmol/l) it
inhibits IP3R, what can be prevented by raising the IP3 concentration, indicating
possible competitive binding of ATP to the IP3-binding domain. On the other side,
dierent modulation of single channel properties of IP3Rs by IP3,C a 2+ and ATP
was observed in patch clamp studies of IP3R channels in the outer membrane of
isolated cell nuclei (Mak et al. 2000, 2001; Boehning et al. 2001). This controversy
among the results obtained in the lipid bilayer and in patch clamp experiments is
not yet resolved.
Despite the fact that dierent calmodulin-binding sites have been charac-
terised in the IP3R, their function remains elusive (for review see Nadif Kasri et al.
2002). CaM inhibited IP3 induced Ca2+-release (IICR), regulated IP3R sensitiv-
ity to Ca2+, and inhibited IP3R-1 in planar lipid bilayer (Michikawa et al. 1999).
However, in some reports the interaction of CaM with the high-anity Ca2+-CaM-
binding site in the modulatory domain of the IP3R-1 did not play a direct role in
biphasic modulation of IP3R-1 by cytosolic Ca2+ or in IP3R-1 inhibition by CaM
(Nosyreva et al. 2002).
A variety of pharmacological compounds modulates IP3R function (for review
see Michelangeli et al. 1995). The most of them function as non-specic modulators.
Only a few compounds activate IP3R directly. Recently, new exogenous compounds
adenophostin A and B from fungal products were found to be full IP3R agonists.
They activated IP3R in the absence of IP3 and were approximately 100-fold more
potent than IP3 (Takahashi et al. 1994). Several pharmacologically active drugs
inhibit IP3Rs non-speci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inhibitor heparin. The compound KN-93, a Ca2+ calmodulin-dependent protein
kinase II (Ca2+/CaMKII) inhibitor, directly inhibited IP3R-1, and the compounds
2-aminoethoxydiphenyl borate (2APB) and curcumin inhibited IICR from cere-
bellar microsomes (Maruyama et al. 1997; Dyer et al. 2002; Smyth et al. 2002).
Uchiyama et al. (2002) developed a recombinant hyperanity IP3 absorbent (IP3
sponge), which has approximately 1000-fold higher anity for the IP3 than the
parental IP3R-1. Trapping IP3 with the IP3 sponge inhibited IICR in cells or mi-
crosomes. The IP3 sponge is a specic and signicant tool for studying IP3-calcium
signalling.
Gene transcription and modulation of IP3R gene expression
Transcription of the IP3Rs is directed from their promoters. A promoter of the
IP3R-1 gene was assigned between −528 to +169 relative to the transcription start
site (Furutama et al. 1996). The IP3R-1 gene has a typical RNA polymerase II-type
promoter with a unique transcription initiation point and a consensus TATA-box
in the promoter. The nucleotide sequence of the 5' region of the human IP3R-1 gene
exposed potential transcription regulatory sites (Figure 2). These potential tran-
scription regulatory sites include the steroid hormone response element (HRE),
CAATT enhancer-binding protein element (C/EBP), retinoic acid responsive el-
ement (RARE), AP-1 and AP-2 sites, NF-B sites and SRE (Kirkwood et al.
1997). Although C/EBP was found in several regions of hippocampus, in cerebel-
lar Purkinje cells and in part of the cortex in the adult brain of mice, it cannot be
responsible exclusively for the predominate expression of the IP3R-1 gene in CNS,
because C/EBP binding site is outside of the region (from −528 to +169) capable
of inducing normal expression patterns in transgenic mice (Furutama et al. 1996).
In both the human and mouse promoter, putative binding sites for transcrip-
tion factors sensitive to retinoic acid were found. The activity of the isolated hu-
man IP3R-1 promoter is decreased by approximately 30% after treatment with 0.5
mol/l retinoic acid for 48 hours. This decrease in human IP3R-1 promoter activity
is likely to be mediated through the AP-2 binding site (Deelman et al. 1998). Also,
endogenous IP3R-1 mRNA is downregulated in A7r5 cells after treatment with
0.5 mol/l retinoic acid for 48 hours, indicating that the endogenous rat IP3R-1
promoter is also sensitive to retinoic acid (Deelman et al. 1998).
HRE      C/EPB    AP1    NF-KB   AP1    SRE  NF-KB
-747                   -330  -262    -145   -52
Figure 2. Potential transcription regulatory sites of the human IP3R-1 gene.300 Krizanova and Ondrias
Comparison of the promoter structures of the three genes of IP3R-1, -2 and -3
revealed that the promoter structures of the ubiquitous IP3R-2 and -3 genes were
obviously distinct from that of the neural IP3R-1 (Tamura et al. 2001). The IP3R-1
promoter contains a TATA element and a single transcription start site, while the
type 2 and 3 receptor genes, have no consensus TATA element and possess multiple
transcription start points (seven for IP3R-2 and four for IP3R-3; Morikawa et al.
1997; Tamura et al. 2001). Seven transcription start points for the IP3R-2 gene
are located around 300 bp upstream from the rst ATG codon and for the IP3R-3
gene there are four transcription start points between positions −325 and −285.
Additionally, from comparison with IP3R-1, these two genes are relatively rich in
G/C nucleotides in their promoter regions (i.e. IP3R-1, 62%; IP3R-2, 73%; IP3R-3,
83%) (Tamura et al. 2001). Moreover, a number of CpG-islands (clusters of CG
or GC) were observed in the control region of IP3R-2 and -3 genes. These features
of a promoter are characteristic of the so-called housekeeping genes that exhibit
ubiquitous expression patterns (Tamura et al., 2001).
The gene encoding the type 1 isoform is subject to alternative splicing and
gives rise to three splice variants that have been denoted as S1, S2 and S3. The S1
splice site is located in the ligand-binding domain, whereas the S2 and S3 splice
sites are in the regulatory domain (Lin et al. 2000). Both the short and the long
form of S1 and S3 appear to coexist in the same tissues, while the expression of
the S2 variant diers in neurons and peripheral tissues (Kocan et al. 2002). The S1
splice site formed by splicing in the middle of the ligand binding domain may alter
the properties of IP3R binding, while the presence or absence of the S2 splice site
may modify regulation of IP3Rs-1, probably through the protein kinase A (PKA)
phosphorylation sites and changes in kinetics (Dano et al. 1991). S2 splicing has
an eect on ATP sensitivity (Tu et al. 2002). The apparent anity to potentiation
by ATP is reduced approximately six-fold in the non-neuronal (peripheral) IP3R-1
S2({) isoform. In contrast, the level of basal activity in the absence of ATP is el-
evated two-fold for the S2({) isoform (Tu et al. 2002). The ATPA site is intact
in IP3R-1 S2({) isoform and the observed changes are likely to be attributable to
overall changes in the conformation of the IP3 coupling domain induced by the S2
splicing event. It is also possible that the additional ATPC site created in IP3R-1
S2({) isoform by S2 excision (Ferris and Snyder 1992)is inhibitory, leading to reduc-
tion in the apparent anity of IP3R-1 for ATP. Boehning et al. (2001) described
the single-channel properties of all, the neuronal (S2(+)), non-neuronal (periph-
eral; S2({)) and recombinant (S2(+/{) IP3R-1 in native mammalian membranes.
No dierences in calcium selectivity and channel gating were observed between
S2(+) and S2({) splice variants (Boehning et al. 2001).
Modulation of the gene expression of IP3Rs can dier according to the tis-
sue. Therefore, we tested the eect of single immobilisation (which is one of the
most potent stressors) for two hours on IP3R-1 in renal medulla (Zacikova et al.
2000), cardiac atria (Lencesova et al. 2002) and stellate ganglia (Micutkova et al.
2003) of rats. In renal medulla of normotensive rats, immobilisation decreased the
gene expression of IP3Rs signicantly within two hours (Zacikova et al. 2000). InIP3 Receptors, Transcriptional Regulation, Phosphorylation 301
stellate ganglia, single exposure to immobilisation stress had no eect on the gene
expression of IP3R-1 (Micutkova et al. 2003). In cardiac atria, gene expression of
IP3Rs-1 and -2 was upregulated by single immobilisation stress for 2 hours and this
increase in gene expression was glucocorticoid-dependent (Lencesova et al. 2002).
Nevertheless, when animals were exposed to repeated immobilisation for 7 days,
two hours daily, a signicant decrease in IP3Rs-1 occurred in all these tissues.
Downregulation of IP3R gene expression was observed also in heart failure
derived from end-stage dilated cardiomyopathy (Barrans et al. 2002). Nevertheless,
it still remains to be elucidated whether downregulation of IP3R si sac a u s e ,o ra
consequence of the pathological stage.
Modulation of IP3R function by phosphorylation
IP3Rs contain consensus sequences for phosphorylation and they have been re-
ported to be phosphorylated by cAMP-dependent PKA (Wojcikiewicz and Luo
1998),protein kinase C (PKC), cGMP-dependent protein kinase G (PKG), CaMKII
and protein tyrosine kinases (PTKs) (for review see Patel et al. 1999; Thrower et
al. 2001). For example, human cerebellum IP3R-1 has the following total num-
ber of consensus phosphorylation sites: 3 for PKA, 6 for PKC, 43 for casein ki-
nase II (CKII), 16 for CaMKII, and 3 for tyrosine kinase (TK) (Patel et al.
1999). This indicates that there is a huge number of combinations of phospho-
rylated/dephosphorylated sites. For example, if there are seven potential phos-
phorylated sites (each monomer equally phosphorylated/dephosphorylated), there
are 128 dierent possible phosphorylation stages of the channel. Since phospho-
rylation/dephosphorylation modulates channel function (Jayaraman et al. 1996;
DeSouza et al. 2002), the eects of phosphorylation/dephosphorylation might be
very complex.
IP3R can undergo also autophosphorylation. Ferris et al. (1992) demonstrated
autophosphorylation of a puried and reconstituted rat cerebellum IP3Ro nas e r -
ine residue and found serine protein kinase activity of the IP3R towards a spe-
cic peptide substrate. Stoichiometric levels of the autophosphorylation were 0.4
mol of phosphate/mol of IP3R. This demonstrated that only a fraction of IP3Rs
was capable of autophosphorylation. Recently, it was reported that protein ki-
nases, melanoma and kidney -kinases were covalently linked with ion channels
(Riazanova et al. 2001). This may indicate that more membrane channels can ex-
hibit kinase activity.
Recent evidence supports a view that IP3Rs function as multiprotein com-
plexes. Several proteins having phosphorylation or dephosphorylation activity were
reported to be associated with IP3Rs. Schlossmann et al. (2000) identied a 125,000
dalton protein IRAG, which was bound to the IP3R-1 and to cGMP-dependent pro-
tein kinase I (cGKI). Stimulation of T-lymphocytes caused a physical association
between the non-receptor PTK in the Src family and IP3R-1 (Jayaramanet al. 1996).302 Krizanova and Ondrias
B-cell scaold protein with ankyrin repeats (BANK), a substrate of TK is as-
sociated with PTK-Lyn and IP3R. BANK promotes PTK-Lyn mediated tyrosine
phosphorylation of IP3R (Yokoyama et al. 2002). A physical association of the pro-
tein phosphatase calcineurin with the IP3R via an immunophilin protein FKBP12
was reported (Cameron et al. 1995). On the other hand, Bultynck et al. (2001) did
not nd a specic, high-anity interaction between IP3R - 1o r- 2w i t hF K B P 1 2 .
Regulation of IP3R by calcineurin and FKBP12 remains controversial.
Recently it was shown that PKA and the protein phosphatases PP1 and PP2A
are components of the IP3R-1 macromolecular signalling complex (DeSouza et al.
2002; Tang et al. 2003). This nding points to the similarities between this com-
plex and that of the closely related ryanodine calcium release channels (RyR1 and
RyR2; Marx et al. 2001). They showed that the RyR1 and RyR2 macromolecular
complexes involve targeting of kinases and phosphatases to the channels via target-
ing proteins that specically bind to leucine/isoleucine zippers on the RyRs. Since
the IP3Rs are phosphorylated or dephosphorylated by associated and free kinases
or phosphatases, the regulation of IP3R by phosphorylation or dephosphorylation
in the intact cells may be dierent from the regulation of puried receptors in
reconstituted systems.
Phosphorylation by PKA
Phosphorylation of IP3Rs by PKA is relatively well characterised (Dano et al.
1991; Ferris et al. 1991; Nakade et al. 1994; Wojcikiewicz and Luo 1998; Haug et
al. 1999; Giovannucci et al. 2000; Pieper et al. 2001; Tang et al. 2003). However,
modulation of IP3R function by phosphorylation is still not fully understood. There
is not full consensus regarding the eects of PKA on the activity of IP3Rs. Several
reports demonstrate that PKA phosphorylation of IP3Rs either increase or decrease
the channel activity.
The isolated neuronal IP3R-1 from rat cerebellum is phosphorylated by cAMP-
and cGMP-dependent protein kinases on two distinct sites, Ser-1589 and Ser-1756
(Ferris et al. 1991). PKA phosphorylated both sites with the same time course and
same stoichiometry, whereas PKG phosphorylated Ser-1755 with a higher velocity
and a higher stoichiometry than Ser-1589 (Haug et al. 1999). IP3R-2 and -3 lack
these consensus PKA phosphorylation sites, although they do contain other puta-
tive PKA phosphorylation sites. To monitor IP3R phosphorylation in vivo,P i e p e r
et al. (2001) developed antibodies that dierentiated IP3R-1 phosphorylated at
Ser-1755 from the unphosphorylated form. They demonstrated that IP3R-1 was
phosphorylated by PKA at Ser-1589 and Ser-1755, with Ser-1755 phosphorylation
greatly predominating in the brain. Striking variations in the regional and subcellu-
lar distribution of IP3R-1 phosphorylation were found, which were regulated by ex-
citatory neurotransmission, excitotoxic insult and neuronal ischaemia-reperfusion.
In non-neuronal tissues alternative splicing results in deletion of a 40 amino acid
exon that aects PKA phosphorylation of the channel resulting in a preferential
phosphorylation of serine 1589 in some tissues (Dano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PKA in the presence of cAMP and of the catalytic subunit of PKA increased
the extent of IICR from canine cerebellum membrane fractions by 35% without
interfering with the binding of IP3 to its receptor sites (Volpe and Alderson-Lang
1990). Phosphorylation of an immunoanity-puried IP3R-1 from mouse cerebel-
lar microsomal fraction was studied after reconstitution into phospholipid vesicles.
The catalytic subunit of PKA stoichiometrically phosphorylated the IP3R-1 pro-
tein and it increased the rate and extent of 45Ca2+ inﬂux into proteoliposomes
by 20% (Nakade et al. 1994). PKA phosphorylation of IP3R-1 augmented Ca2+
release (Pieper et al. 2001) and increased channel activity in planar lipid bilayers
(DeSouza et al. 2002; Tang et al. 2003). Phosphorylation of IP3R in intact hep-
atocytes cells was associated with an increase of its sensitivity to Ca2+ and IP3
(Joseph and Ryan 1993). IP3R-1, -2 and -3 were dierentially susceptible to PKA
phosphorylation and were phosphorylated in intact human neuroblastoma, rat pan-
creatoma and rat insulinoma cells (Wojcikiewicz and Luo 1998). PKA enhanced
IP3-induced Ca2+ mobilisation by  20% in a range of permeabilised cell types,
irrespective of whether the type 1, 2, or 3 receptor was predominant. PKA phospho-
rylated IP3R-2 in parotid acinar cells and dramatically potentiated Ca2+ release
(Bruce et al. 2002). The interpretation of indirect studies of IP3R activation by
PKA phosphorylation may be complicated by the ndings that cAMP can raise
intracellular calcium independently of PKA (den Dekker et al. 2002).
Phosphorylation of IP3R-1 from cerebellum caused a decrease in Ca2+ re-
lease (Supattapone et al. 1988). Phosphorylation of IP3R-1 by endogenous kinases
in intact platelets resulted in high IICR, whereas additional PKA phosphorylation
inhibited IICR (Quinton et al. 1996). Elevation of cAMP in intact single megakary-
ocytes inhibited IP3-induced rise in intracellular Ca2+ and PKA inhibitors blocked
the inhibitory eect, indicating that the inhibition was induced by PKA (Tertysh-
nikova and Fein 1998). PKA-dependent phosphorylation of IP3R-3 inhibited Ca2+
release in pancreatic acinar cells at a low concentration of IP3, whereas PKA had
little eect on the release at high doses of IP3 (Giovannucci et al. 2000). PKA
shaped oscillations in pancreatic acinar cells by phosphorylation of IP3R-3 (Straub
et al. 2002).
The discrepancy between the eects of PKA phosphorylation on IP3R activity
observedby various investigators may be partially explained by misinterpretation of
the Ca2+ release activity due to the confounding opposing contribution of increased
ER Ca2+ pump (uptake) activity in response to PKA phosphorylation as well as by
dierent \phosphorylation stages" of the IP3R complex in dierent experiments.
Phosphorylation by PKG
PKG phosphorylation of IP3R-1 decreased IP3-induced calcium release. Activa-
tion of PKG eectively suppressed thrombin-induced stimulation of IP3 production
(Ruth et al. 1993). IICR was inhibited by cGMP in intact rat megakaryocytes via
PKG and PKA (Tertyshnikova and Fein 1998). In permeabilised and intact rabbit
stomach muscle cells, PKG inhibited IICR (Murthy 2001). IRAG and cGKI are
part of the multicomponent complex physically interacting with IP3R-1 (Schloss-304 Krizanova and Ondrias
mann et al. 2000). They are involved in regulation of IICR. By phosphorylation of
IRA, cGKI decreased the IP3-dependent release through IP3R-1. Up to four ser-
ine residues in IRAG were phosphorylated cGKI, but phosphorylation of Ser-696
was necessary to decrease calcium release (Ammendola et al. 2001).
Phosphorylation by PTK
PTK phosphorylation of IP3R-1 increased IP3-induced calcium release. IP3R-1
contains two potential tyrosine phosphorylation sites at residues 482 and 2617
(Michikawa et al. 1994). Thrombin activation of human platelets was accompanied
by tyrosine phosphorylation of IP3R and by a transient enhancement in platelet
cytosolic Ca2+, but this enhancement was attenuated by subsequent dephosphory-
lation. Jayaraman et al. (1996) observed that stimulation of T-lymphocytes caused
a physical association between the PTK-Fyn and IP3R, followed by tyrosine phos-
phorylation of IP3R-1 and resulting in an increase in the open probability of the
channel. PTK-Lyn mediated tyrosine phosphorylation of IP3R in B-cells, resulting
in its increased activity (Yokoyama et al. 2002). Major cell adhesion molecules,
CD44v10 and Rho-kinase (ROK) are physically associated as a complex in aor-
tic endothelial cells. Activation of the cells promoted RhoA-mediated ROK activ-
ity, which, in turn, increased phosphorylation of IP3R-1 and, to a lesser extent,
of IP3R-2 and -3. The phosphorylated IP3R-1 is enhanced in its binding to IP3,
which subsequently stimulates IP3-mediated Ca2+ ﬂux (Singleton and Bourguignon
2002).
Phosphorylation by other kinases
CaMKII can phosphorylate IP3R-1 but the exact site of phosphorylation is still
unknown (Ferris et al. 1991). An IICR in permeabilised 3T6 broblasts was acti-
vated probably by CaMKII and inhibited by Ca2+-dependent protein phosphatase
2B (Zhang et al. 1993). Cerebellar membranes containing IP3R-1 phosphorylated
by PKC or CaMKII displayed a greater potency for IP3 in stimulating Ca2+ ﬂux
compared with membranes treated with a specic inhibitor of CaMKII (Cameron
et al. 1995).
Conclusion
Modulation of both transcription and phosphorylationaects the function of IP3Rs.
As it can be seen from this minireview, both processes are very complex. Despite
a huge amount of information there is still plenty of ambiguity in IP3R research,
from regulatory aspects to the function of these systems. To analyse the precise
function of the IP3R-1, IP3R-1 decient mice have been generated by gene targeting
(Matsumoto et al., 1996). Most of the homozygous IP3R-1 decient mice died in
utero and the rest suered of ataxia and convulsion and died before the weaning
period. Ogura and co-workers (2001) examined the heterozygous IP3R decient
mice and found that IP3R-1 plays a substantial role in the motor coordination.IP3 Receptors, Transcriptional Regulation, Phosphorylation 305
The function of IP3R-2 and -3 is still not known. Further research is certainly
needed to clarify unknown aspects of these channels.
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